HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 26.40
Day range
kr 24.20 - kr 27.20
Year range
kr 17.84 - kr 134.00
Market cap
71.78M SEK
Avg Volume
10.98K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.18M | -4.64% |
Operating expense | 19.74M | -11.69% |
Net income | -15.64M | 12.22% |
Net profit margin | -718.04 | 7.95% |
Earnings per share | — | — |
EBITDA | -19.30M | 4.38% |
Effective tax rate | 19.19% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.54M | 41.57% |
Total assets | 104.53M | 40.77% |
Total liabilities | 40.11M | 200.95% |
Total equity | 64.42M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.09 | — |
Return on assets | -47.12% | — |
Return on capital | -71.65% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.64M | 12.22% |
Cash from operations | -5.50M | 63.31% |
Cash from investing | 43.00K | 326.32% |
Cash from financing | 9.47M | 465.43% |
Net change in cash | 5.14M | 126.23% |
Free cash flow | -2.01M | — |
About
Founded
2015
Website
Employees
20
